Models for Evaluating Therapeutic Resistance of Depression

Abstract

We present a review of existing models for evaluating treatment-resistant depression (TRD). Their main advantages and drawbacks are identified, and the potential for using them in clinical practice is assessed. A new spectral model of TRD is presented, which considers the clinical spectrum of types (variants) of TRD; this model requires further development.